• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Private Equity Firm

Hand passing wad of bills to other hand
Manufacturing

CDMO Wilmington PharmaTech snares investment from Curewell

With the extra cash, WPT plans to expand its production capacity and further scale its end-to-end capabilities for small molecule API in the U.S.
Fraiser Kansteiner Oct 21, 2025 10:00am
MA

Bavarian Nordic confirms buyout talks

Jul 24, 2025 11:13am
Saplings growing with increasing denominations of money wrapped around them

Manufacturer PCI snares 'sizable' private equity investment

Jul 15, 2025 8:30am
increase

Bluebird investor reluctance pays off with better buyout offer

May 14, 2025 10:40am
warning

Bluebird warns of potential bankruptcy amid buyout delay

May 13, 2025 9:56am
Acquisitions

Bain Capital lays out $3.3B to acquire Mitsubishi Tanabe Pharma

Feb 7, 2025 11:26am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings